Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.
Searching online for stem cell therapy can be confusing. Some pages describe careful, regulated medical care, while others make bold promises that no clinician can honestly keep. If you are an international patient considering adipose-derived stem cell therapy in Japan, learning how to read this information critically is a useful first step. This article offers practical questions to ask before you ever book a consultation.
Why does stem cell information online vary so much in quality?
Regenerative medicine is a fast-moving field. Laboratory studies, early clinical trials and approved treatments are often discussed together, even though they represent very different levels of evidence. A promising result in cells grown in a dish does not automatically mean a treatment works the same way in people.
Mesenchymal stem cells, which can be obtained from fat tissue, have been reported in research to secrete anti-inflammatory substances and growth factors. Studies are ongoing worldwide, and results differ depending on the condition, the cell preparation and the study design. For that reason, a trustworthy source will describe what has been reported, what remains uncertain, and what is still being studied, rather than presenting a single study as proof.
What signs suggest a source is being careful and balanced?
When you read a clinic page, a news article or a social media post, a few habits can help you judge its reliability.
- It explains uncertainty and limits, not only potential benefits.
- It avoids words that guarantee results, such as promises of a cure or of dramatic change.
- It points to public sources such as PubMed, government agencies or academic societies.
- It states clearly that treatment decisions depend on a physician’s examination.
- It does not replace standard medical care with an unproven option, and it respects the role of your current doctors.
Patient testimonials and before-and-after photographs can feel persuasive, but they are individual stories. They cannot show how a treatment works for a different person with a different health background, so they are not a sound basis for a medical decision.
How is adipose-derived stem cell therapy provided in Japan?
At Grand Green Osaka Umekita Clinic, adipose-derived stem cell therapy is offered as a regenerative treatment using your own cells. In general terms, a small amount of fat tissue is collected under local anesthesia, mesenchymal stem cells are cultured and expanded at a specialized facility, and the cells are later returned to the body by intravenous infusion. Because the cells come from you, the treatment is described as autologous.
In Japan, this type of treatment is provided under the Act on the Safety of Regenerative Medicine, which requires a regenerative medicine provision plan and oversight of how cells are handled. This system is one reason it is worth asking any clinic to explain, in plain language, how its plan is organized and what safety management looks like. It is also important to know that this treatment is a self-pay service, which means it is not covered by public health insurance in Japan.
What should you ask before booking a consultation in Osaka?
A good consultation is a two-way conversation. Preparing questions in advance helps you use the time well, especially if you are communicating across languages. You may find the following topics helpful.
- Which conditions or goals is the treatment intended to support, and what is the basis for that?
- What are the possible risks and side effects, and how are they monitored?
- What does the full process involve, from fat collection and cell culture to infusion and follow-up?
- What are the costs, how many sessions may be needed, and what is the expected time frame?
- Who may not be suitable for the treatment, and what screening takes place first?
- How can your medical records and prior test results be shared in advance?
Because costs, risks, side effects and suitability vary from person to person, they should be confirmed directly with a physician during your examination rather than assumed from a web page. A clinic that welcomes these questions is showing you something valuable about how it communicates.
How can language support and planning help international patients?
Medical terms are difficult enough in your first language. For international patients and residents in Japan, clear communication is part of safe care. Grand Green Osaka Umekita Clinic is located in the Umeda area of Osaka, which is easy to reach from many parts of Japan and from abroad, and it provides an information page for foreign patients so that you can review basic guidance in advance.
It can help to write down your medical history, current medications, allergies and any questions in a short document before you visit. If you are traveling for treatment, think about how follow-up will work after you return home, and whether your local doctor will be informed. Discussing these points early supports a more realistic and calmer decision.
Key takeaways for a careful decision
Adipose-derived stem cell therapy is an area of active research, and evidence is still developing. The most reliable approach is to combine public information, a clear explanation of the regulatory framework, and a personal examination by a physician. Be cautious of any source that promises certain outcomes or minimizes risk.
If you are considering this treatment, use the questions above as a starting point. A consultation can help you understand whether the therapy fits your situation, and you are always free to take time, seek a second opinion and keep your current doctors informed.
- Check your sourcesLook for balanced information
- Know the rulesRegulated in Japan
- See a physicianConfirm costs and risks
- Prepare questions
This diagram is a conceptual overview that summarizes the article
References
- PubMed: Regenerative medicine strategies for hair growth and regeneration: A narrative review of literature. (2022)
- PubMed: Therapeutic potential of mesenchymal stem cell-derived extracellular vesicles: A focus on inflammatory bowel disease. (2024)
- PubMed: Adipose-Derived Mesenchymal Stem Cells in the Treatment of Diabetic Foot Ulcers: A Review of Preclinical and Clinical Studies. (2020)
- PubMed: Why Use Adipose-Derived Mesenchymal Stem Cells in Tendinopathic Patients: A Systematic Review. (2022)
- PubMed: Adipose-Derived Mesenchymal Stem Cells for the Treatment of Articular Cartilage: A Systematic Review on Preclinical and Clinical Evidence. (2015)
- PMC: Human clinical evidence on stem cell-based therapies for ischemic stroke: An umbrella review with emphasis on mesenchymal stem cells. (2026)
- PMC: Sources and Clinical Applications of Mesenchymal Stem Cells: State-of-the-art review. (2018)
- PMC: The role and mechanism of mesenchymal stem cells in immunomodulation of type 1 diabetes mellitus and its complications: recent research progress and challenges: a review. (2025)
- MHLW (Japan): Regenerative Medicine — Ministry of Health, Labour and Welfare, Japan
Supervising Physician
Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic
Hidenori Shimada
Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.
* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.